FDA, States Start Compounding Pharmacy Discussion

The Food and Drug Administration conferred with public health officials from 50 states for the first time about how best to strengthen rules governing compounding pharmacies in the wake of a national meningitis outbreak caused by a tainted pain medication produced by a Massachusetts pharmacy.
December 20, 2012
 

The Food and Drug Administration conferred with public health officials from 50 states for the first time about how best to strengthen rules governing compounding pharmacies in the wake of a national meningitis outbreak caused by a tainted pain medication produced by a Massachusetts pharmacy.

Join the Discussion

After you comment, click Post. You can enter an anonymous Display Name or connect to a social profile.

More from Health & Human Services